Articles

Sort by
Previous Page Page 2 of 23 Next Page
  1. Research

    When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans

    Since the identification of BRCA1 there has only ever been described two bi-allelic mutation carriers, one of whom was subsequently shown to be a mono-allelic carrier. The second patient diagnosed with two BRCA1 ...

    Michelle Wong-Brown, Mary McPhillips, Margaret Gleeson, Allan D. Spigelman, Cliff J. Meldrum, Susan Dooley and Rodney J. Scott

    Hereditary Cancer in Clinical Practice 2016 14:6

    Published on: 16 February 2016

  2. Research

    Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland

    Mutations in the BRCA1, BRCA2 and PALB2 genes are well-established risk factors for the development of breast and/or ovarian cancer. The frequency and spectrum of mutations in these genes has not yet been exam...

    P. Wojcik, M. Jasiowka, E. Strycharz, M. Sobol, D. Hodorowicz-Zaniewska, P. Skotnicki, T. Byrski, P. Blecharz, E. Marczyk, I. Cedrych, J. Jakubowicz, J. Lubiński, V. Sopik, S. Narod and P. Pierzchalski

    Hereditary Cancer in Clinical Practice 2016 14:5

    Published on: 3 February 2016

  3. Research

    Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer

    Treatment outcomes appear to be better for ovarian cancer (OC) patients carrying the BRCA1/2 germline mutation than for patients with sporadic OC. However, most published data are for North American, British and ...

    Wiktor Szatkowski, Paweł Blecharz, Jerzy W. Mituś, Marek Jasiówka, Elżbieta Łuczyńska, Jerzy Jakubowicz and Tomasz Byrski

    Hereditary Cancer in Clinical Practice 2016 14:4

    Published on: 23 January 2016

  4. Research

    BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population

    Gastric cancer (GC) is part of the spectrum of diseases linked to BRCA1 and BRCA2 mutations that increase the risk of breast and ovarian cancer. Data suggesting an increased risk of developing GC among BRCA1 and

    Małgorzata Ławniczak, Anna Jakubowska, Andrzej Białek, Jan Lubiński, Katarzyna Jaworska–Bieniek, Katarzyna Kaczmarek and Teresa Starzyńska

    Hereditary Cancer in Clinical Practice 2016 14:3

    Published on: 15 January 2016

  5. Research

    Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes

    Breast cancer (BC) is an important public health problem worldwide. In Brazil, breast cancer is the most frequently diagnosed tumor and the leading cause of cancer death in women. Hereditary cancer represents ...

    Gabriela C. Fernandes, Rodrigo A. D. Michelli, Cristovam Scapulatempo-Neto and Edenir I. Palmero

    Hereditary Cancer in Clinical Practice 2016 14:2

    Published on: 13 January 2016

  6. Research

    Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients

    The role of germline mutations in BRCA1 and BRCA2 genes in the risk of the development of ovarian cancer is clinically well established. BRCA1/2 testing seems to have increasing role in clinical management in pat...

    Agnieszka Synowiec, Gabriel Wcisło, Lubomir Bodnar, Bohdan Górski, Jolanta Szenajch, Katarzyna Szarlej-Wcisło and Cezary Szczylik

    Hereditary Cancer in Clinical Practice 2016 14:1

    Published on: 8 January 2016

  7. Meeting abstract

    Magnesium as a diagnostic marker of cancer

    Wojciech Marciniak, Magdalena Muszyńska, Katarzyna Jaworska-Bieniek, Katarzyna Kaczmarek, Grzegorz Sukiennicki, Marcin Lener, Katarzyna Durda, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Oleg Oszurek, Cezary Cybulski, Tadeusz Dębniak, Antoni Morawski, Anna Jakubowska and Jan Lubiński

    Hereditary Cancer in Clinical Practice 2015 13(Suppl 2):A6

    Published on: 26 November 2015

    This article is part of a Supplement: Volume 13 Supplement 2

  8. Meeting abstract

    Zinc as diagnostic marker of cancers

    Katarzyna Kaczmarek, Magdalena Muszyńska, Katarzyna Jaworska-Bieniek, Wojciech Marciniak, Grzegorz Sukiennicki, Marcin Lener, Katarzyna Durda, Tomasz Gromowski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Oleg Oszurek, Cezary Cybulski, Tadeusz Dębniak, Antoni Morawski, Anna Jakubowska…

    Hereditary Cancer in Clinical Practice 2015 13(Suppl 2):A4

    Published on: 26 November 2015

    This article is part of a Supplement: Volume 13 Supplement 2

  9. Meeting abstract

    Copper as diagnostic marker of cancers

    Magdalena Muszyńska, Wojciech Marciniak, Katarzyna Jaworska-Bieniek, Katarzyna Kaczmarek, Grzegorz Sukiennicki, Marcin Lener, Katarzyna Durda, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Oleg Oszurek, Cezary Cybulski, Tadeusz Dębniak, Antoni Morawski, Anna Jakubowska and Jan Lubiński

    Hereditary Cancer in Clinical Practice 2015 13(Suppl 2):A7

    Published on: 26 November 2015

    This article is part of a Supplement: Volume 13 Supplement 2

  10. Meeting abstract

    Iron as diagnostic marker of cancer

    Grzegorz Sukiennicki, Magdalena Muszyńska, Katarzyna Jaworska-Bieniek, Katarzyna Kaczmarek, Wojciech Marciniak, Marcin Lener, Katarzyna Durda, Tomasz Gromowski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Oleg Oszurek, Cezary Cybulski, Tadeusz Dębniak, Antoni Morawski, Anna Jakubowska…

    Hereditary Cancer in Clinical Practice 2015 13(Suppl 2):A5

    Published on: 26 November 2015

    This article is part of a Supplement: Volume 13 Supplement 2

  11. Meeting abstract

    Selenium as diagnostic marker of cancers

    Katarzyna Jaworska-Bieniek, Magdalena Muszyńska, Katarzyna Kaczmarek, Wojciech Marciniak, Grzegorz Sukiennicki, Marcin Lener, Katarzyna Durda, Tomasz Gromowski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Oleg Oszurek, Cezary Cybulski, Tadeusz Dębniak, Antoni Morawski, Anna Jakubowska…

    Hereditary Cancer in Clinical Practice 2015 13(Suppl 2):A3

    Published on: 26 November 2015

    This article is part of a Supplement: Volume 13 Supplement 2

  12. Letter to the Editor

    The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine

    Germ-line mutations in several genes, such as BRCA1 and BRCA2, are known to increase the risk of breast cancer. These heritable mutations are unequally represented among populations with different ethnic backgrou...

    Ielizaveta Gorodetska, Svitlana Serga, Natalia Levkovich, Tetiana Lahuta, Ludmila Ostapchenko, Serhyi Demydov, Nikolay Anikusko, Valeriy Cheshuk, Ivan Smolanka, Svitlana Sklyar, Serhyi Polenkov, Oleksander Boichenko and Iryna Kozeretska

    Hereditary Cancer in Clinical Practice 2015 13:19

    Published on: 13 October 2015

Previous Page Page 2 of 23 Next Page